K-numberK251368
Device nameFETOLY
ApplicantDiagnoly
Product codeIYN
Device classClass II
Decision dateSep 12, 2025
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

FETOLY is software that uses machine learning to analyze fetal ultrasound images in real-time to automatically detect fetal heart and brain views, identify quality criteria within those views, and provide biometric measurements. It is intended as a concurrent reading aid during routine fetal heart and brain examinations in the second and third trimesters (17–40 weeks gestational age) for qualified ultrasound professionals.

Technological characteristics

FETOLY expands the predicate device (FETOLY-HEART) by adding fetal brain detection and measurement capabilities alongside heart analysis. It detects nine ultrasound views (five cardiac, four brain) versus five cardiac-only in the predicate, identifies 95 quality criteria (52 heart + 43 brain) versus 52 heart-only, and provides eight biometric measurements including cardiac angles and ratios plus brain cephalic index, versus cardiac measurements only.

Test standards cited

IEC 62304 (software verification testing); acceptance criteria based on sensitivity ≥85% and specificity ≥85% for view detection, ≥90% sensitivity/specificity for heart quality criteria detection, and limits of agreement thresholds for biometric measurements validated against reference standards established using a 2+1 ground truth annotation procedure.

Substantial equivalence argument

FETOLY is substantially equivalent because it shares the same intended use, user population, and clinical application (concurrent ultrasound reading aid) as predicate FETOLY-HEART. The expansion to brain views and measurements does not raise new safety or effectiveness questions because performance testing on 750 patient cases (completeness) and 441 patient cases (measurements) across diverse subgroups demonstrates sensitivity and specificity meeting or exceeding acceptance criteria. The brain measurement functionality is addressed by reference device FETAL HS (Voluson Expert), confirming biometric measurement equivalence. The frozen machine learning model with a predetermined change control plan ensures controlled future modifications.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →